BRAF and melanoma: In line with PREX2 deficiency, this mutation had no impact upon disease trajectory, with naevus onset, melanoma initiation, and overall survival of BRAF PTEN PREX2-GD animals equivalent to the BRAF PTEN control cohort (Fig. 1E; Supplementary Fig. S2D).